Bill Text: CT SB00036 | 2016 | General Assembly | Comm Sub

Connecticut Senate Bill 36 (Prior Session Legislation)

Bill Title: An Act Concerning Health Insurance Coverage Of Orally And Intravenously Administered Medications.

Spectrum: Committee Bill

Status: (Introduced - Dead) 2016-04-08 - Favorable Report, Tabled for the Calendar, Senate [SB00036 Detail]

Download: Connecticut-2016-SB00036-Comm_Sub.html


General Assembly		*Raised Bill No. 36*
*February Session, 2016*		LCO No. 448
		_____SB00036APP___040716____
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)

AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective January 1, 2017) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state individual health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.

Sec. 2. (NEW) (Effective January 1, 2017) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state group health insurance policies providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 of the general statutes and that provide coverage for intravenously administered medications for the treatment or palliation or therapeutic intervention for the prevention of disabling or life-threatening chronic diseases shall provide coverage for orally administered medications for such treatment, palliation or intervention on a basis no less favorable than intravenously administered medications.